A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

NCT03869320 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ACT-1004-1239
OTHER: Placebo
DRUG: ACT-1004-1239 (Food-effect subpart)
OTHER: Placebo (Food-effect subpart)

Sponsor

Idorsia Pharmaceuticals Ltd.